A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge.

MLA

Ndungo, Esther, et al. “A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity Following Oral Vaccination and Experimental Challenge.” MSphere, vol. 3, no. 4, Aug. 2018. EBSCOhost, https://doi.org/10.1128/mSphere.00260-18.

APA

Ndungo, E., Randall, A., Hazen, T. H., Kania, D. A., Trappl-Kimmons, K., Liang, X., Barry, E. M., Kotloff, K. L., Chakraborty, S., Mani, S., Rasko, D. A., & Pasetti, M. F. (2018). A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity following Oral Vaccination and Experimental Challenge. MSphere, 3(4). https://doi.org/10.1128/mSphere.00260-18

Chicago

Ndungo, Esther, Arlo Randall, Tracy H Hazen, Dane A Kania, Krista Trappl-Kimmons, Xiaowu Liang, Eileen M Barry, et al. 2018. “A Novel Shigella Proteome Microarray Discriminates Targets of Human Antibody Reactivity Following Oral Vaccination and Experimental Challenge.” MSphere 3 (4). doi:10.1128/mSphere.00260-18.